Manulife (Manufacturers Life Insurance)’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,743
| Closed | -$70K | – | 3018 |
|
|
2020
Q3 | $70K | Hold |
2,743
| – | – | ﹤0.01% | 2865 |
|
|
2020
Q2 | $76K | Buy |
2,743
+234
| +9% | +$6.48K | ﹤0.01% | 2815 |
|
|
2020
Q1 | $121K | Sell |
2,509
-29
| -1% | -$1.4K | ﹤0.01% | 2519 |
|
|
2019
Q4 | $144K | Sell |
2,538
-173
| -6% | -$9.82K | ﹤0.01% | 2704 |
|
|
2019
Q3 | $177K | Sell |
2,711
-131
| -5% | -$8.55K | ﹤0.01% | 2649 |
|
|
2019
Q2 | $128K | Buy |
2,842
+1,302
| +85% | +$58.6K | ﹤0.01% | 2834 |
|
|
2019
Q1 | $97K | Buy |
1,540
+223
| +17% | +$14K | ﹤0.01% | 2578 |
|
|
2018
Q4 | $71K | Sell |
1,317
-230
| -15% | -$12.4K | ﹤0.01% | 2468 |
|
|
2018
Q3 | $155K | Sell |
1,547
-1,801
| -54% | -$180K | ﹤0.01% | 2828 |
|
|
2018
Q2 | $221K | Buy |
3,348
+464
| +16% | +$30.6K | ﹤0.01% | 3046 |
|
|
2018
Q1 | $144K | Sell |
2,884
-23
| -0.8% | -$1.15K | ﹤0.01% | 3260 |
|
|
2017
Q4 | $141K | Sell |
2,907
-224
| -7% | -$10.9K | ﹤0.01% | 3265 |
|
|
2017
Q3 | $191K | Buy |
3,131
+336
| +12% | +$20.5K | ﹤0.01% | 3021 |
|
|
2017
Q2 | $198K | Buy |
2,795
+781
| +39% | +$55.3K | ﹤0.01% | 3013 |
|
|
2017
Q1 | $130K | Buy |
2,014
+239
| +13% | +$15.4K | ﹤0.01% | 3071 |
|
|
2016
Q4 | $166K | Buy |
1,775
+57
| +3% | +$5.33K | ﹤0.01% | 2933 |
|
|
2016
Q3 | $194K | Buy |
1,718
+151
| +10% | +$17.1K | ﹤0.01% | 2794 |
|
|
2016
Q2 | $128K | Buy |
1,567
+1,422
| +981% | +$116K | ﹤0.01% | 3072 |
|
|
2016
Q1 | $7K | Buy |
+145
| New | +$7K | ﹤0.01% | 3712 |
|